paclitaxel has been researched along with Non-ST Elevated Myocardial Infarction in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Böhm, M; Clever, YP; Degenhardt, R; El-Garhy, M; Ewen, S; Kische, S; Lauer, B; Mahfoud, F; Ohlow, MA; Richter, S; Rudolph, TK; Scheller, B; Wagner, A | 1 |
Baber, U; Camenzind, E; Chieffo, A; Dangas, GD; Faggioni, M; Farhan, S; Galatius, S; Giustino, G; Harari, R; Itchhaporia, D; Jeger, RV; Kandzari, D; Kastrati, A; Kim, HS; Kimura, T; Leon, MB; Mehran, R; Mehta, L; Morice, MC; Sartori, S; Serruys, PW; Sharma, M; Smits, PC; Sorrentino, S; Stefanini, GG; Steg, PG; Stone, GW; Valgimigli, M; Von Birgelen, C; Weisz, G; Wijns, W; Windecker, S | 1 |
Eränen, J; Kärkkäinen, JM; Mäntylä, P; Mustonen, J; Rissanen, TT; Siljander, A; Uskela, S | 1 |
Bil, J; Costa, RA; Gil, KE; Gil, RJ; Vassiliev, D | 1 |
2 trial(s) available for paclitaxel and Non-ST Elevated Myocardial Infarction
Article | Year |
---|---|
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Non-ST Elevated Myocardial Infarction; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional | 2020 |
12-month intravascular ultrasound observations from BiOSS® first-in-man studies.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Non-ST Elevated Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2016 |
2 other study(ies) available for paclitaxel and Non-ST Elevated Myocardial Infarction
Article | Year |
---|---|
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; ST Elevation Myocardial Infarction; Treatment Outcome | 2017 |
Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2019 |